Bone Density Decline: Tenofovir has actually been connected with a decrease in bone mineral density, growing the potential risk of bone complications or fractures.HIV-1 contaminated subjects on dolutegravir monotherapy demonstrated immediate and dose-dependent reduction of antiviral action with declines of HIV-one RNA copies for each ml. The antivi